Vectorite Biomedica inc
24-02-2006: AMDL, Inc. announced that it has signed a Memorandum of Understanding (MOU) with Vectorite Biomedica, Inc., a Taiwan based company, that could lead to the development of human and animal clinical trials in Taiwan of AMDL's Combination Immunogene Therapy (CIT), a therapeutic vaccine.